Philadelphia, PA45 Active Studies

Pulmonary Embolism Clinical Trials in Philadelphia, PA

Find 45 actively recruiting pulmonary embolism clinical trials in Philadelphia, PA. Connect with local research sites and explore new treatment options.

45
Active Trials
32
Sponsors
11,754
Enrolling

Recruiting Pulmonary Embolism Studies in Philadelphia

About Pulmonary Embolism Clinical Trials in Philadelphia

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 45 pulmonary embolism clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 11,754 participants. Research is being sponsored by University of Pennsylvania, Jennifer Lewey, MD, MPH, Thomas Jefferson University and 29 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Philadelphia — FAQ

Are there pulmonary embolism clinical trials in Philadelphia?

Yes, there are 45 pulmonary embolism clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 45 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated October 15, 2026 from ClinicalTrials.gov